To provide accessible and innovative genetic technologies, products and services for all.

Sansure Biotech Inc. is an in vitro diagnostic solution provider integrating diagnostic reagents, instruments and independent clinic laboratory services with its own innovative gene technology as its core. The company is committed to becoming a genetic technology provider, and is a National Demonstration Centre for the Application of Genetic Testing Technology and a National Joint Local Engineering Research Center for Genetic Diagnosis of Infection Diseases and Tumours.

Headquartered in Changsha, the company has built the new Industrial Park in Shanghai to create a production base for precise and intelligent molecular diagnostic systems and an important international hub, and set up branches or affiliates in nearly 20 cities, including Beijing, Guangzhou, Chongqing and Xi'an.

The company has developed a series of internationally leading core technologies and more than 500 products with performance exceeding the advanced level at home and abroad. All of the new technologies and products have lead the domestic industry to catch up with the international advanced level, and is now breaking the monopoly of imports and promoting the application of gene technology from individual departments to multiple departments in medical institutions, from high-end laboratories in large hospitals to all levels of hospitals including primary medical institutions, and from a few fields to all scenarios.

Since the early days of COVID-19, Sansure has successfully developed new nucleic acid detection reagents and rapid detection instruments. The SARS-CoV-2 nucleic acid test developed by Sansure Biotech has served more than 160 countries and regions worldwide.

During the epidemic, sansure donated nearly 170 million yuan worth of anti-epidemic materials to domestic and foreign countries and helped thousands of laboratories to improve their nucleic acid testing capabilities.

We have provided nucleic acid testing solutions for many countries and regions around the world, which has further enabled countries worldwide to understand China's epidemic prevention solutions and experience, highlighting its strength of China.

"Innovating diagnostics for all". The company will always adhere to the "innovation + service" dual-wheels drive, adhere to the idea of “every dose of reagent requires precision and high quality, and every diagnosis is related to the health of the patient”; to develop more affordable and well used gene technology, products and services, export the "Sansure solution" for the benefit people all over the world, help China seize the world's high ground in genetic technology and build a healthy community with shared future for mankind, and strive to promote genetic technology as the backbone of human health services.


Innovating Diagnostics For All.

Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.

Thank you!

We shall contact you soon!
Back Top